Onderneming CTI BioPharma Corp.
Aandelen
CTIC
US12648L6011
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 128
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20-03-17 |
David Kirske
DFI | Director of Finance/CFO | 69 | 01-08-17 |
John Volpone
HRO | Human Resources Officer | - | - |
Jim Fong
PRN | Corporate Officer/Principal | 62 | 01-01-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20-03-17 |
Laurent Fischer
CHM | Chairman | 60 | 21-07-17 |
David Parkinson
BRD | Director/Board Member | 73 | 05-06-17 |
Reed Tuckson
BRD | Director/Board Member | 73 | 01-09-11 |
Diane Parks
BRD | Director/Board Member | 72 | 24-08-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 3 047 | 0 | 0 | 95,47 % |
Aandeel B | 1 | 131 880 176 | 125 911 110 ( 95,47 %) | 0 |
Bedrijfsgegevens
CTI BioPharma Corp.
3101 Western Avenue Suite 800
98121, Seattle
+206 282 7100
http://www.ctibiopharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,17% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+5,23% | 24,63 mld. | |
-24,79% | 18,2 mld. | |
+26,69% | 12,01 mld. | |
-3,13% | 11,76 mld. | |
+6,57% | 10,4 mld. | |
-18,08% | 9,94 mld. |